University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement

• Post author:GHIAA Admin
• Post published:January 11, 2022
• Post category:

Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement

MSD – MPP, Molnupiravir License Agreement

• Post author:GHIAA Admin
• Post published:November 22, 2021
• Post category:

Continue ReadingMSD – MPP, Molnupiravir License Agreement

Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

• Post author:GHIAA Admin
• Post published:September 10, 2021
• Post category:

Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 23, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement

Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

• Post author:GHIAA Editor
• Post published:July 1, 2021
• Post category:

Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

BMGF – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingBMGF – CureVac, Global Access Commitments Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingCEPI – CureVac, Framework Partnering Agreement

CEPI – Novavax, COVID-19 Vaccine Funding Agreement

• Post author:GHIAA Editor
• Post published:May 14, 2021
• Post category:

Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement